A Riboflavin Phosphate, Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Riboflavin Phosphate, Sodium Certificate of Suitability (COS). The purpose of a Riboflavin Phosphate, Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Riboflavin Phosphate, Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Riboflavin Phosphate, Sodium to their clients by showing that a Riboflavin Phosphate, Sodium CEP has been issued for it. The manufacturer submits a Riboflavin Phosphate, Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Riboflavin Phosphate, Sodium CEP holder for the record. Additionally, the data presented in the Riboflavin Phosphate, Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Riboflavin Phosphate, Sodium DMF.
A Riboflavin Phosphate, Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Riboflavin Phosphate, Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Riboflavin Phosphate, Sodium suppliers with CEP (COS) on PharmaCompass.